#efficacy

@drtimos.bsky.social

1 day ago

ATS_2025_Social_Media_Report_by_LucidQuest.pdf Bitly is dedicated to making the internet a safer place for everyone. Use the site preview above to make sure the link takes you where you expect.

🚀 #ATS2025 buzz check! #COPD, #Asthma & #Pulmonology dominate, with #Data (~21%) & #Efficacy (~18%) driving talk. 82% positive vibes on AI & therapy breakthroughs. 📊🫁 Dive into our full report! http://dlvr.it/TRTBHw #SocialListening #LucidQuest #ATS25 @atscommunity @ATS_AII

0 0 0 0

@drtimos.bsky.social

2 days ago

ASCO_GU_ 2025_Social_Media_Report.pdf drive.google.com/file/d/1Q1DrPio5c6P4F3VeL-5b3UCSo7DR9hXm/view

🚀 Dive into #ASCOGU25 buzz!

Top themes: #Efficacy 20%, #Data 19%, #ClinicalTrials 15%.

#ProstateCancer & #BladderCancer dominate, 75% positive vibes on new immunotherapy wins. 📊🩺

Download our full report http://dlvr.it/TRRj7w !

#Oncology #SocialListening #LucidQuest

0 0 0 0

@drtimos.bsky.social

3 days ago

ASCO GI 2025 SoMe Report.pdf Bitly is dedicated to making the internet a safer place for everyone. Use the site preview above to make sure the link takes you where you expect.

🚀 Get the #Oncology buzz from #ASCOGI25!

Top themes: #Efficacy 16.2%, #ClinicalTrials 16.1%, #Data 15.9%. #CRCsm & #GIOnc dominate, with #ctDNA & #Immunotherapy hot topics. 📊🩺

Download our full report! http://dlvr.it/TRQxmX
@ASCO

#SocialListening #LucidQuest

0 0 0 0

@chardo-rstrategyu.bsky.social

5 days ago

Your power comes from within. ✨
When you build Hope, Efficacy, Resilience, and Optimism, you become unstoppable.
#InnerHERO #PsyCap #Leadership #SelfDevelopment #Hope #Resilience #Efficacy #Optimism #mindsetmatters

1 0 0 0

@drtimos.bsky.social

1 week ago

ATS_2025_Social_Media_Report_by_LucidQuest.pdf Bitly is dedicated to making the internet a safer place for everyone. Use the site preview above to make sure the link takes you where you expect.

🚀 #ATS2025 buzz check! #COPD, #Asthma & #Pulmonology dominate, with #Data (~21%) & #Efficacy (~18%) driving talk. 82% positive vibes on AI & therapy breakthroughs. 📊🫁 Dive into our full report! http://dlvr.it/TRHQBl #SocialListening #LucidQuest #ATS25 @atscommunity @ATS_AII

0 0 0 0

@drtimos.bsky.social

1 week ago

ASCO_GU_ 2025_Social_Media_Report.pdf drive.google.com/file/d/1Q1DrPio5c6P4F3VeL-5b3UCSo7DR9hXm/view

🚀 Dive into #ASCOGU25 buzz!

Top themes: #Efficacy 20%, #Data 19%, #ClinicalTrials 15%.

#ProstateCancer & #BladderCancer dominate, 75% positive vibes on new immunotherapy wins. 📊🩺

Download our full report http://dlvr.it/TRGBBY !

#Oncology #SocialListening #LucidQuest

1 0 0 0

@drtimos.bsky.social

1 week ago

ASCO GI 2025 SoMe Report.pdf Bitly is dedicated to making the internet a safer place for everyone. Use the site preview above to make sure the link takes you where you expect.

🚀 Get the #Oncology buzz from #ASCOGI25!

Top themes: #Efficacy 16.2%, #ClinicalTrials 16.1%, #Data 15.9%. #CRCsm & #GIOnc dominate, with #ctDNA & #Immunotherapy hot topics. 📊🩺

Download our full report! http://dlvr.it/TRF805
@ASCO

#SocialListening #LucidQuest

0 0 0 0

@drtimos.bsky.social

2 weeks ago

ATS_2025_Social_Media_Report_by_LucidQuest.pdf Bitly is dedicated to making the internet a safer place for everyone. Use the site preview above to make sure the link takes you where you expect.

🚀 #ATS2025 buzz check! #COPD, #Asthma & #Pulmonology dominate, with #Data (~21%) & #Efficacy (~18%) driving talk. 82% positive vibes on AI & therapy breakthroughs. 📊🫁 Dive into our full report! http://dlvr.it/TR6KTD #SocialListening #LucidQuest #ATS25 @atscommunity @ATS_AII

0 0 0 0

@drtimos.bsky.social

3 weeks ago

ASCO_GU_ 2025_Social_Media_Report.pdf drive.google.com/file/d/1Q1DrPio5c6P4F3VeL-5b3UCSo7DR9hXm/view

🚀 Dive into #ASCOGU25 buzz!

Top themes: #Efficacy 20%, #Data 19%, #ClinicalTrials 15%.

#ProstateCancer & #BladderCancer dominate, 75% positive vibes on new immunotherapy wins. 📊🩺

Download our full report http://dlvr.it/TR5FBn !

#Oncology #SocialListening #LucidQuest

0 0 0 0

@drtimos.bsky.social

3 weeks ago

ASCO GI 2025 SoMe Report.pdf

🚀 Get the #Oncology buzz from #ASCOGI25!

Top themes: #Efficacy 16.2%, #ClinicalTrials 16.1%, #Data 15.9%. #CRCsm & #GIOnc dominate, with #ctDNA & #Immunotherapy hot topics. 📊🩺

Download our full report! http://dlvr.it/TR4sCY
@ASCO

#SocialListening #LucidQuest

0 0 0 0

Qiwei Luna Wu, PhD

@lunawu.bsky.social

3 weeks ago

Internalizing Patient-Centered Communication: Pathways to Telehealth Efficacy in Cancer Care As telehealth becomes increasingly central to cancer care, many patients still report low confidence navigating digital communication with providers. Grounded in self-determination theory, this stu...

🚨New Pub🚨

We explored the #conceptualization of #PCC as an external motivation of #telehealth #efficacy.
Also tested how the previously one-dimensional #patient #activation could be operationalized in 4 steps, translating PCC into telehealth-specific efficacy.

www.tandfonline.com/eprint/NZQMT...

0 0 0 0

@drtimos.bsky.social

1 month ago

ATS_2025_Social_Media_Report_by_LucidQuest.pdf Bitly is dedicated to making the internet a safer place for everyone. Use the site preview above to make sure the link takes you where you expect.

🚀 #ATS2025 buzz check! #COPD, #Asthma & #Pulmonology dominate, with #Data (~21%) & #Efficacy (~18%) driving talk. 82% positive vibes on AI & therapy breakthroughs. 📊🫁 Dive into our full report! http://dlvr.it/TQy60q #SocialListening #LucidQuest #ATS25 @atscommunity @ATS_AII

1 0 0 0

@drtimos.bsky.social

1 month ago

ASCO_GU_ 2025_Social_Media_Report.pdf drive.google.com/file/d/1Q1DrPio5c6P4F3VeL-5b3UCSo7DR9hXm/view

🚀 Dive into #ASCOGU25 buzz!

Top themes: #Efficacy 20%, #Data 19%, #ClinicalTrials 15%.

#ProstateCancer & #BladderCancer dominate, 75% positive vibes on new immunotherapy wins. 📊🩺

Download our full report http://dlvr.it/TQwYdy !

#Oncology #SocialListening #LucidQuest

0 0 0 0

@drtimos.bsky.social

1 month ago

ASCO GI 2025 SoMe Report.pdf

🚀 Get the #Oncology buzz from #ASCOGI25!

Top themes: #Efficacy 16.2%, #ClinicalTrials 16.1%, #Data 15.9%. #CRCsm & #GIOnc dominate, with #ctDNA & #Immunotherapy hot topics. 📊🩺

Download our full report! http://dlvr.it/TQvxV7
@ASCO

#SocialListening #LucidQuest

0 0 0 0

@drtimos.bsky.social

1 month ago

ATS_2025_Social_Media_Report_by_LucidQuest.pdf Bitly is dedicated to making the internet a safer place for everyone. Use the site preview above to make sure the link takes you where you expect.

🚀 #ATS2025 buzz check! #COPD, #Asthma & #Pulmonology dominate, with #Data (~21%) & #Efficacy (~18%) driving talk. 82% positive vibes on AI & therapy breakthroughs. 📊🫁 Dive into our full report! http://dlvr.it/TQmjqy #SocialListening #LucidQuest #ATS25 @atscommunity @ATS_AII

0 0 0 0

@drtimos.bsky.social

1 month ago

ASCO_GU_ 2025_Social_Media_Report.pdf 2025 Genitourinary Cancers Symposium Accelerate your success ASCO GU 2025 • Social Media Insights at Medical / Scientific Congresses 3 • Our methodology 4 • Key takeaways 5 • Conference-related SM activity over time 6 • Top hashtags used 7 • Top discussion themes 8 • Top Leading Voices 9 • Sentiment Analysis 10 • Most frequently used words and phrases 11 • LucidQuest’s SM Insights’ capabilities 12 • Get in touch 13 1. Insights on which and which to avoid hashtags that can to your preferred resonates with with existing or The LucidQuest Social Media Insights team monitored approximately 16.1K posts before, during, and after ASCO GU 2025 to identify key hashtags, top discussion themes, top Our team analyzed the absolute frequency of relevant hashtags found in 2.5K posts, and compiled a list of the top most frequent ones. The text of top 500 posts was analyzed to identify the top discussion themes and most frequent phrases and words used. We leveraged our LQ algorithm, which takes into account both user activity and popularity, to identify the top Leading Voices at the event. Finally, we analyzed the text of top 500 posts to assess overall sentiment and audience perceptions of the conference We filtered posts in the top 25% of views to identify the top 500 ones.

🚀 Dive into #ASCOGU25 buzz!

Top themes: #Efficacy 20%, #Data 19%, #ClinicalTrials 15%.

#ProstateCancer & #BladderCancer dominate, 75% positive vibes on new immunotherapy wins. 📊🩺

Download our full report http://dlvr.it/TQlR2m !

#Oncology #SocialListening #LucidQuest

0 0 0 0

@drtimos.bsky.social

1 month ago

ASCO GI 2025 SoMe Report.pdf 403. That’s an error. We're sorry, but you do not have access to this page. That’s all we know.

🚀 Get the #Oncology buzz from #ASCOGI25!

Top themes: #Efficacy 16.2%, #ClinicalTrials 16.1%, #Data 15.9%. #CRCsm & #GIOnc dominate, with #ctDNA & #Immunotherapy hot topics. 📊🩺

Download our full report! http://dlvr.it/TQkJJF
@ASCO

#SocialListening #LucidQuest

0 0 0 0

Giuseppe Michieli

@gmik69bsky.bsky.social

1 month ago

Protective #efficacy of a genetically modified attenuated #vaccinia virus #Tiantan strain against #monkeypox virus challenge in a small animal #model

Protective #efficacy of a genetically modified attenuated #vaccinia virus #Tiantan strain against #monkeypox virus challenge in a small animal #model, etidiohnew.blogspot.com/2026/01/prot...

0 0 0 0

@drtimos.bsky.social

1 month ago

ATS_2025_Social_Media_Report_by_LucidQuest.pdf

🚀 #ATS2025 buzz check! #COPD, #Asthma & #Pulmonology dominate, with #Data (~21%) & #Efficacy (~18%) driving talk. 82% positive vibes on AI & therapy breakthroughs. 📊🫁 Dive into our full report! http://dlvr.it/TQbRtN #SocialListening #LucidQuest #ATS25 @atscommunity @ATS_AII

0 0 0 0

@drtimos.bsky.social

1 month ago

ASCO_GU_ 2025_Social_Media_Report.pdf drive.google.com/file/d/1Q1DrPio5c6P4F3VeL-5b3UCSo7DR9hXm/view

🚀 Dive into #ASCOGU25 buzz!

Top themes: #Efficacy 20%, #Data 19%, #ClinicalTrials 15%.

#ProstateCancer & #BladderCancer dominate, 75% positive vibes on new immunotherapy wins. 📊🩺

Download our full report http://dlvr.it/TQZ1zb !

#Oncology #SocialListening #LucidQuest

0 0 0 0

@drtimos.bsky.social

1 month ago

ASCO GI 2025 SoMe Report.pdf 403. That’s an error. We're sorry, but you do not have access to this page. That’s all we know.

🚀 Get the #Oncology buzz from #ASCOGI25!

Top themes: #Efficacy 16.2%, #ClinicalTrials 16.1%, #Data 15.9%. #CRCsm & #GIOnc dominate, with #ctDNA & #Immunotherapy hot topics. 📊🩺

Download our full report! http://dlvr.it/TQYRN4
@ASCO

#SocialListening #LucidQuest

0 0 0 0

@drtimos.bsky.social

1 month ago

ATS_2025_Social_Media_Report_by_LucidQuest.pdf

🚀 #ATS2025 buzz check! #COPD, #Asthma & #Pulmonology dominate, with #Data (~21%) & #Efficacy (~18%) driving talk. 82% positive vibes on AI & therapy breakthroughs. 📊🫁 Dive into our full report! http://dlvr.it/TQRMpy #SocialListening #LucidQuest #ATS25 @atscommunity @ATS_AII

0 0 0 0

@drtimos.bsky.social

1 month ago

ASCO_GU_ 2025_Social_Media_Report.pdf drive.google.com/file/d/1Q1DrPio5c6P4F3VeL-5b3UCSo7DR9hXm/view

🚀 Dive into #ASCOGU25 buzz!

Top themes: #Efficacy 20%, #Data 19%, #ClinicalTrials 15%.

#ProstateCancer & #BladderCancer dominate, 75% positive vibes on new immunotherapy wins. 📊🩺

Download our full report http://dlvr.it/TQQByH !

#Oncology #SocialListening #LucidQuest

0 0 0 0

@drtimos.bsky.social

1 month ago

ASCO GI 2025 SoMe Report.pdf Bitly is dedicated to making the internet a safer place for everyone. Use the site preview above to make sure the link takes you where you expect.

🚀 Get the #Oncology buzz from #ASCOGI25!

Top themes: #Efficacy 16.2%, #ClinicalTrials 16.1%, #Data 15.9%. #CRCsm & #GIOnc dominate, with #ctDNA & #Immunotherapy hot topics. 📊🩺

Download our full report! http://dlvr.it/TQPfK2
@ASCO

#SocialListening #LucidQuest

0 0 0 0

Out of the Trenches podcast

@outoftrenchespc.bsky.social

1 month ago

Read the #show notes from the latest #podcast episode with Glenn Forbes & Jenni Donohoo who talk about ow to counteract each of the enemies of #teacher #efficacy
danagoodier.com/episodes-388...

0 1 0 0

Endocrine Society Journals

@endosocjournals.bsky.social

1 month ago

Immune Checkpoint Inhibitors in High-grade Gastroenteropancreatic Neuroendocrine Neoplasms Abstract. High-grade gastroenteropancreatic (GEP) neuroendocrine neoplasms (HG-NENs) comprise both highly proliferating well-differentiated NENs, called gr

Immune Checkpoint Inhibitors in High-grade Gastroenteropancreatic Neuroendocrine Neoplasms. Read more in #EndocrineReviews: bit.ly/44vELgI #HighGradeNeuroendocrineNeoplasms #ImmuneCheckpointInhibitors #Efficacy @endocrinesociety.bsky.social

0 0 0 0

@drtimos.bsky.social

2 months ago

ATS_2025_Social_Media_Report_by_LucidQuest.pdf Bitly is dedicated to making the internet a safer place for everyone. Use the site preview above to make sure the link takes you where you expect.

🚀 #ATS2025 buzz check! #COPD, #Asthma & #Pulmonology dominate, with #Data (~21%) & #Efficacy (~18%) driving talk. 82% positive vibes on AI & therapy breakthroughs. 📊🫁 Dive into our full report! http://dlvr.it/TQHLC0 #SocialListening #LucidQuest #ATS25 @atscommunity @ATS_AII

0 0 0 0

@drtimos.bsky.social

2 months ago

ASCO_GU_ 2025_Social_Media_Report.pdf

🚀 Dive into #ASCOGU25 buzz!

Top themes: #Efficacy 20%, #Data 19%, #ClinicalTrials 15%.

#ProstateCancer & #BladderCancer dominate, 75% positive vibes on new immunotherapy wins. 📊🩺

Download our full report http://dlvr.it/TQGMGG !

#Oncology #SocialListening #LucidQuest

0 0 0 0

@drtimos.bsky.social

2 months ago

ASCO GI 2025 SoMe Report.pdf

🚀 Get the #Oncology buzz from #ASCOGI25!

Top themes: #Efficacy 16.2%, #ClinicalTrials 16.1%, #Data 15.9%. #CRCsm & #GIOnc dominate, with #ctDNA & #Immunotherapy hot topics. 📊🩺

Download our full report! http://dlvr.it/TQFj65
@ASCO

#SocialListening #LucidQuest

0 0 0 0

@drtimos.bsky.social

2 months ago

ATS_2025_Social_Media_Report_by_LucidQuest.pdf Bitly is dedicated to making the internet a safer place for everyone. Use the site preview above to make sure the link takes you where you expect.

🚀 #ATS2025 buzz check! #COPD, #Asthma & #Pulmonology dominate, with #Data (~21%) & #Efficacy (~18%) driving talk. 82% positive vibes on AI & therapy breakthroughs. 📊🫁 Dive into our full report! http://dlvr.it/TQ7mpG #SocialListening #LucidQuest #ATS25 @atscommunity @ATS_AII

0 0 0 0

Posts tagged #efficacy